Physician profile
Kelley D Brummett
NPI 1952403719
$14,498.82
in general payments reported to CMS, 2019-2025
15 companies · $755 in 2025
The $755 reported for 2025 was more than what 94% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,637 · 2020: $1,669 · 2021: $1,534 · 2022: $221 · 2023: $6,733 · 2024: $949 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,500 · Education: $3,488 · Food and Beverage: $431 · Entertainment: $18.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,500.00 |
| Education | $3,488.05 |
| Food and Beverage | $431.30 |
| Entertainment | $18.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dmg America LLC | $11,019.75 | 2019-2023 | Honigum, Tempocem Id, Luxatemp Ultra |
| Zimvie INC. | $1,649.92 | 2023-2025 | |
| Peter Brasseler Holdings, LLC | $1,049.29 | 2019-2024 | |
| A-Dec, INC. | $313.30 | 2021 | |
| Ivoclar Vivadent, INC. | $175.72 | 2022 | |
| Salvin Dental Specialties, INC. | $90.50 | 2019 | |
| Align Technology, INC. | $75.74 | 2022-2024 | Invisalign |
| Biolase, INC. | $19.98 | 2022 | |
| Coltene Whaledent INC. | $18.45 | 2024 | |
| Ultradent Products INC | $17.72 | 2024-2025 | Opalescence |
| Zimmer Biomet Holdings, INC. | $16.11 | 2020 | |
| 3m Company | $15.11 | 2021 | |
| Benco Dental Supply Co. | $12.81 | 2021 | |
| Gc America INC. | $12.52 | 2022 | |
| Dentsply Sirona INC | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelley Brummett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.